Spring 2022 (Volume 32, Number 1)
Survey Results: Reflections
on Rheumatology
Download PDF
In light of the CRA’s milestone 75th anniversary, this
issue’s survey asked our members for their personal reflections
on rheumatology.
The first question respondents were asked was “Why is
rheumatology important to you?” Many of the responses
mentioned meaningful patient connections combined
with stimulating medicine.
One respondent wrote, “It provided me with a stimulating
career in an evolving and close-knit specialty, and
the opportunity to work longitudinally with patients to
improve their lives. The rheumatology sphere in Canada is
collegial, supportive, and welcoming.”
Another said, “The humble lens under which rheumatology
sees the world is inclusive, broad, respectful and
mindful of all the contributing cogs and wheels within the
human body, unparalleled in any other specialty.”
And another commented, “It is an art and a science; it is
absolutely fulfilling in that we see the results of our therapeutic
efforts in great outcomes for our patients.”
This question was followed by “What is the biggest
breakthrough in rheumatology you have experienced first-hand?”
Responses included the following:
- The advent of biologics (mentioned
in several responses)
- Treat-to-target approach in rheumatoid arthritis (RA)
- Improved description of phenotypes of myositis
- Advancements in diagnostic imaging
and laboratory testing
- The development and evolution of the
Canadian Rheumatology Association
- Development of agreed outcome measures
- Deconstruction of pain and its attribution
One respondent summed up the biggest breakthroughs
as follows: “1) Biologics and other advanced therapies: revolutionized
patient care and enhanced the appeal of rheumatology
as a specialty and; 2) Treat-to-target approach
in RA; Even though all our target measures are flawed, they
ensure a better therapeutic strategy. This is exemplified by
quotations from the eminent physicist Lord Kelvin ‘If you
cannot measure it, you cannot improve it,’ and the management
guru Peter Drucker ‘You can't manage what you
can't measure.’”
The last question asked members, “What do you see in
store for the future of rheumatology?”
Responses included the following:
- More team-based care
- Narrowing scope of rheumatology practice
towards inflammatory diseases
- Improved pathways to care for patients
- Increased use of virtual and asynchronous
care where appropriate
- Precision medicine
- Personalization of care and customization
of treatment regimens
- More rheumatologists and greater diversity
- More understanding of the conditions we treat
- Quality improvement measures to use our existing
resources wisely with awareness of resource limitations
- More ultrasound use in rheumatology
- Better understanding of therapeutic targets
- Wider acceptance of models of interprofessional care
to provide optimal, cost-effective outcomes/remission
- An effective treatment for osteoarthritis
As one commenter put it, “The future of rheumatology
is the ruralization of rheumatology care. We need to work
with nurses, physiotherapists, occupational therapists,
pharmacists, and family physicians stationed in rural Canada
to deliver the same excellence of care being provided
in urban areas. We will need remote data gathering devices,
upcoming ultrasound technologies that scan and report
by artificial intelligence techniques, and all the tools
telemedicine can muster to achieve this.”
The CRA would love to hear your reflections on rheumatology. For any questions and feedback on the survey,
please reach out to Kevin Baijnauth at Kbaijnauth@rheum.ca.
|